GlassScriptPhysician profile
Kelli L Virgin
NPI 1124464268
$1,113.72
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $432 · 2021: $215 · 2022: $74.44 · 2023: $193 · 2024: $47.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $239.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $209.01 | 2019-2024 | Rybelsus, Ozempic |
| W. L. Gore & Associates, INC. | $139.48 | 2020 | |
| Endologix LLC | $137.45 | 2020 | |
| Xeris Pharmaceuticals, INC. | $93.00 | 2020-2023 | Gvoke Hypopen |
| Abbott Laboratories | $89.03 | 2020-2023 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.88 | 2019-2023 | Jardiance |
| Ultragenyx Pharmaceutical INC. | $60.29 | 2022-2023 | Crysvita |
| Janssen Pharmaceuticals, INC | $51.74 | 2019 | |
| Insulet Corporation | $47.06 | 2021-2024 | Omnipod |
| Amgen INC. | $46.55 | 2020-2021 | |
| Medtronic Minimed, INC. | $37.30 | 2019 | |
| Medtronic, INC. | $30.64 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $30.30 | 2020 | |
| Dexcom, INC. | $22.01 | 2020 | |
| Sanofi-Aventis U.S. LLC | $20.81 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $16.33 | 2021 | |
| Lilly USA, LLC | $11.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelli Virgin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.